CurrentCardio
Get Weekly

Cardiovascular journalCurrentCardio coverage

European Journal of Heart Failure

What CurrentCardio has captured from this journal. The coverage figures describe CurrentCardio's coverage, not the journal's output. Figures as of 13 October 2026.

Recent
36 Briefs
past 90 days
Archive
582 Briefs
research published Apr 2023 – Dec 2026
Editorial
–
no Weekly issue published yet
Impact Factor
10.3
2025 · Journal Citation Reports

Topics

Evidence types

Shares are of the 582 Briefs CurrentCardio has covered from Eur J Heart Fail, by primary topic and study type; a Brief without a primary topic is in no topic row.

Publication activity

Latest from European Journal of Heart Failure

All coverage, newest first

  1. Eur J Heart Fail

    “Baseline Characteristics and Utilization of Medical Therapies in Acute Hospitalized and Chronic Heart Failure Patients Enrolled in GRASP-HF: Differences Between ICARe-HF and Non-ICARe-HF Centres”

    Cohort studyHeart failure

  2. Eur J Heart Fail

    GDMT is Associated with Reduced Loop Diuretic Requirements, Whereas Diuretic Dose Does Not Modify GDMT Benefit in Heart Failure: STRONG-HF.

    Secondary analysisHeart failure

  3. Eur J Heart Fail

    Clinical trajectory and disease progression in patients with cardio-renal-metabolic syndrome: the CaReMap observational study

    Cohort studyCardiometabolic & kidney

  4. Eur J Heart Fail

    Kidney function decline, heart failure hospitalization, and the effect of empagliflozin in heart failure: an EMPEROR-pooled analysis

    Meta-analysisHeart failure

  5. Eur J Heart Fail

    Determinants and associations of health-related quality of life with mortality in acute and chronic heart failure: findings from the ESC HF III Registry

    Cohort studyHeart failure

  6. Eur J Heart Fail

    Pharmacological treatment strategies to prevent heart failure across the cardiovascular-kidney-metabolic spectrum: an EJHF Expert Consensus Statement

    Guideline or statementHeart failure

  7. Eur J Heart Fail

    Effectiveness of Finerenone in Slowing Chronic Kidney Disease Progression After Hospitalization for Heart Failure: A FIDELITY Subgroup Analysis

    Secondary analysisCardiometabolic & kidney

  8. Eur J Heart Fail

    Longitudinal proteomic organ-specific aging in heart failure

    Cohort studyHeart failure

  9. Eur J Heart Fail

    Mortality benefit and lifetime survival gains with vericiguat in HFrEF: Bayesian and actuarial analyses of the VICTOR trial

    Secondary analysisHeart failure

  10. Eur J Heart Fail

    Phenotype-specific prognostic implications of pulse pressure in heart failure

    Meta-analysisHeart failure

  11. Eur J Heart Fail

    Efficacy of vericiguat by background guideline-directed medical therapy in the VICTOR trial

    Secondary analysisHeart failure

  12. Eur J Heart Fail

    Early and late transcatheter aortic valve implantation outcomes in aortic stenosis with transthyretin cardiac amyloidosis: a systematic review

    Meta-analysisValvular & structural

  13. Eur J Heart Fail

    Contemporary decongestion strategies in acute heart failure: an individual patient data analysis of three randomized controlled trials

    Meta-analysisHeart failure

  14. Eur J Heart Fail

    Type 2 diabetes and chronic kidney disease combinations in heart failure across the ejection fraction spectrum: clinical associations, medication use, and cause-specific outcomes: a contemporary, real-world analysis of the Swedish Heart Failure Registry

    Cohort studyHeart failure

  15. Eur J Heart Fail

    Gut microbiome-derived metabolites as prognostic biomarkers in heart failure: a systematic review and meta-analysis

    Meta-analysisHeart failure

  16. Eur J Heart Fail

    Diurnal variation in left atrial pressure in ambulatory patients with chronic heart failure

    Cohort studyHeart failure

  17. Eur J Heart Fail

    Time in blood pressure range and cardiovascular outcomes in HFmrEF/HFpEF: a pooled participant-level analysis of four large-scale trials

    Meta-analysisHeart failure

  18. Eur J Heart Fail

    Cost-effectiveness of digitoxin in heart failure with reduced ejection fraction in the European Union and the United States

    Research articleHeart failure

  19. Eur J Heart Fail

    Treatment effects of dapagliflozin in patients with aortic stenosis undergoing transcatheter aortic valve implantation across left ventricular ejection fraction

    Secondary analysisValvular & structural

  20. Eur J Heart Fail

    The C-MIC II follow-up study: safety and efficacy results 12 months after deactivation of cardiac microcurrent therapy

    Cohort studyHeart failure

  21. Eur J Heart Fail

    Heart Failure and Cancer: Incidence and Mortality Patterns, A Systematic Review and Meta-analysis

    Meta-analysisCardio-oncology & other

  22. Eur J Heart Fail

    Iron deficiency and bone metabolism in heart failure

    Cross-sectional studyHeart failure

  23. Eur J Heart Fail

    Persistent atrial myopathy despite ventricular recovery: prognostic significance of discordant LV–LA strain patterns in HFrEF

    Cohort studyHeart failure

  24. Eur J Heart Fail

    Strategies for preventing and reversing atrial cardiomyopathy: current evidence, therapeutic targets, and future directions. A European Journal of Heart Failure expert consensus statement

    Guideline or statementHeart failure

  25. Eur J Heart Fail

    Finerenone and apparent treatment-resistant hypertension in heart failure with mildly reduced or preserved ejection fraction

    Secondary analysisHeart failure

  26. Eur J Heart Fail

    Catheter ablation in end-stage heart failure with atrial fibrillation: an hierarchical endpoint analysis of the CASTLE-HTx trial

    Secondary analysisArrhythmias & EP

  27. Eur J Heart Fail

    Target Versus Below-Target Dose ACE Inhibitors in U.S. Veterans with HFpEF: Differential Outcomes by CKD Status

    Cohort studyHeart failure

  28. Eur J Heart Fail

    Sex differences in exercise training response among HFpEF patients: pooled analysis of OptimEx-Clin and Ex-DHF-trials

    Meta-analysisHeart failure

  29. Eur J Heart Fail

    Spironolactone in the Treatment of Heart Failure with Mildly Reduced or Preserved Ejection Fraction: Design and Baseline Characteristics of the SPIRIT-HF-DZHK08 Trial

    Randomised controlled trialHeart failure

  30. Eur J Heart Fail

    The role of circulating polyunsaturated fatty acids in atrial fibrillation and atrial cardiomyopathy a machine learning-informed structural modelling approach

    Cohort studyArrhythmias & EP

  31. Eur J Heart Fail

    Electromechanical profiling in genotyped dilated cardiomyopathy with left bundle branch block

    Cohort studyHeart failure

  32. Eur J Heart Fail

    Short-term survival of dual SGLT2i-MRA and four-class guideline-directed medical therapy in acute heart failure

    Cohort studyHeart failure

  33. Eur J Heart Fail

    Trends in mortality, heart transplantation, and left ventricular assist device use in advanced heart failure between 2003 and 2022: data from the Swedish Heart Failure Registry

    Cohort studyHeart failure

  34. Eur J Heart Fail

    A NETwork meta-analysis with COST-effectiveness evaluation of pharmacological treatments for heart failure with reduced ejection fraction: NET-COST-HFrEF

    Meta-analysisHeart failure

  35. Eur J Heart Fail

    Catheter ablation of atrial fibrillation in patients with heart failure: a trial-level meta-analysis

    Meta-analysisArrhythmias & EP

  36. Eur J Heart Fail

    Urinary biomarker thresholds to detect diuretic resistance and insufficient diuretic response in acute heart failure

    Diagnostic or prognostic studyHeart failure

  37. Eur J Heart Fail

    Cardiac myosin-binding protein C in community-based patients with suspected heart failure

    Diagnostic or prognostic studyHeart failure

  38. Eur J Heart Fail

    First Italian multicentre registry for Mechanically Assisted Circulatory Support (ITAMACS) report: 12-year experience of over 1000 durable LVAD patients

    Cohort studyHeart failure

  39. Eur J Heart Fail

    A high proportion of children with severe cardiomyopathies show both myocarditis and genetic predispositions

    Cohort studyHeart failure

  40. Eur J Heart Fail

    Prevention of heart failure in women: an expert consensus statement on sex-specific risk factors

    Guideline or statementHeart failure

All 582 Briefs in ExploreShowing the 40 most recently published